Induction Healthcare (UK) Performance
| INHC Stock | 9.00 0.00 0.00% |
Induction Healthcare has a performance score of 3 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.45, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Induction Healthcare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Induction Healthcare is expected to be smaller as well. Induction Healthcare right now retains a risk of 3.45%. Please check out Induction Healthcare semi deviation, coefficient of variation, jensen alpha, as well as the relationship between the downside deviation and information ratio , to decide if Induction Healthcare will be following its current trending patterns.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Induction Healthcare Group are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Induction Healthcare may actually be approaching a critical reversion point that can send shares even higher in December 2024. ...more
1 | Pound falls and FTSE 100 weaker before budget - Marketscreener.com | 10/30/2024 |
2 | Top UK Penny Stocks To Watch In November 2024 - Yahoo Finance | 11/11/2024 |
| Begin Period Cash Flow | 4.3 M |
Induction |
Induction Healthcare Relative Risk vs. Return Landscape
If you would invest 850.00 in Induction Healthcare Group on September 1, 2024 and sell it today you would earn a total of 50.00 from holding Induction Healthcare Group or generate 5.88% return on investment over 90 days. Induction Healthcare Group is generating 0.1455% of daily returns and assumes 3.4483% volatility on return distribution over the 90 days horizon. Simply put, 30% of stocks are less volatile than Induction, and 98% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Induction Healthcare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Induction Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Induction Healthcare Group, and traders can use it to determine the average amount a Induction Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0422
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | INHC | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.45 actual daily | 30 70% of assets are more volatile |
Expected Return
| 0.15 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Induction Healthcare is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Induction Healthcare by adding it to a well-diversified portfolio.
Induction Healthcare Fundamentals Growth
Induction Stock prices reflect investors' perceptions of the future prospects and financial health of Induction Healthcare, and Induction Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Induction Stock performance.
| Return On Equity | -0.17 | ||||
| Return On Asset | -0.1 | ||||
| Profit Margin | (0.31) % | ||||
| Operating Margin | (0.62) % | ||||
| Current Valuation | 4.81 M | ||||
| Shares Outstanding | 93.85 M | ||||
| Price To Book | 0.46 X | ||||
| Price To Sales | 0.66 X | ||||
| Revenue | 13.65 M | ||||
| Gross Profit | 4.99 M | ||||
| EBITDA | (165 K) | ||||
| Net Income | (3.26 M) | ||||
| Total Debt | 57 K | ||||
| Book Value Per Share | 0.19 X | ||||
| Cash Flow From Operations | (1.09 M) | ||||
| Earnings Per Share | (0.03) X | ||||
| Total Asset | 33.37 M | ||||
| Retained Earnings | (22.52 M) | ||||
About Induction Healthcare Performance
Assessing Induction Healthcare's fundamental ratios provides investors with valuable insights into Induction Healthcare's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Induction Healthcare is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Induction Healthcare is entity of United Kingdom. It is traded as Stock on LSE exchange.Things to note about Induction Healthcare performance evaluation
Checking the ongoing alerts about Induction Healthcare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Induction Healthcare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Induction Healthcare had very high historical volatility over the last 90 days | |
| The company reported the revenue of 13.65 M. Net Loss for the year was (3.26 M) with profit before overhead, payroll, taxes, and interest of 4.99 M. | |
| Induction Healthcare generates negative cash flow from operations | |
| About 54.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Top UK Penny Stocks To Watch In November 2024 - Yahoo Finance |
- Analyzing Induction Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Induction Healthcare's stock is overvalued or undervalued compared to its peers.
- Examining Induction Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Induction Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Induction Healthcare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Induction Healthcare's stock. These opinions can provide insight into Induction Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Induction Stock Analysis
When running Induction Healthcare's price analysis, check to measure Induction Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Induction Healthcare is operating at the current time. Most of Induction Healthcare's value examination focuses on studying past and present price action to predict the probability of Induction Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Induction Healthcare's price. Additionally, you may evaluate how the addition of Induction Healthcare to your portfolios can decrease your overall portfolio volatility.